ESTIMATION OF THE MODERN MUCOLYTIC THERAPY EFFICACY IN CHILDREN, SUFFERING FROM MUCOVISCIDOSIS (TWO YEAR EXPERIENCE OF DORNASE ALFA APPLICATION)

Complications from the part of the respiratory apparatus are the main reason for the lethality among patients, suffering from mucoviscidosis. The adequate mucolytic therapy is of great importance in the complex treatment of the chronic bronchopulmonary process. In 2004, in Omsk center of mucoviscido...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: E.B. Pavlinova (Author), A.G. Mingairova (Author), T.I. Safonova (Author), T.Yu. Korneyeva (Author)
Format: Knjiga
Izdano: "Paediatrician" Publishers LLC, 2007-03-01T00:00:00Z.
Teme:
Online dostop:Connect to this object online.
Oznake: Označite
Brez oznak, prvi označite!